Bayer Aktiengesellschaft (BAYRY)
USD 6.24
(1.13%)
USD 6.24
(1.13%)
| Year | Eps | Eps Growth |
|---|---|---|
| 2023 | -2.99 EUR | -170.85% |
| 2022 | 4.22 EUR | 313.73% |
| 2021 | 1.02 EUR | 106.44% |
| 2020 | -15.84 EUR | -738.71% |
| 2019 | 2.48 EUR | 451.11% |
| 2018 | 0.45 EUR | -51.09% |
| 2017 | 0.92 EUR | -32.35% |
| 2016 | 1.36 EUR | 9.68% |
| 2015 | 1.24 EUR | 20.39% |
| 2014 | 1.03 EUR | 6.19% |
| 2013 | 0.97 EUR | 32.88% |
| 2012 | 0.73 EUR | -2.67% |
| 2011 | 0.75 EUR | 92.31% |
| 2010 | 0.39 EUR | -9.3% |
| 2009 | 0.43 EUR | -23.21% |
| 2008 | 0.56 EUR | -25.33% |
| 2007 | 0.75 EUR | 31.58% |
| 2006 | 0.57 EUR | 23.91% |
| 2005 | 0.46 EUR | -6.12% |
| 2004 | 0.49 EUR | -49.48% |
| 2003 | 0.97 EUR | 169.44% |
| 2002 | 0.36 EUR | 12.5% |
| 2001 | 0.32 EUR | -48.39% |
| 2000 | 0.62 EUR | -10.14% |
| 1999 | 0.69 EUR | 25.45% |
| 1998 | 0.55 EUR | 0.0% |
| Year | Eps | Eps Growth |
|---|---|---|
| 2024 Q2 | -0.03 EUR | -101.7% |
| 2024 Q1 | 2.04 EUR | 50.0% |
| 2023 Q2 | -1.92 EUR | -186.49% |
| 2023 Q4 | 1.36 EUR | 129.25% |
| 2023 Q1 | 2.22 EUR | 258.06% |
| 2023 Q3 | -4.65 EUR | -142.19% |
| 2023 FY | - EUR | -170.85% |
| 2022 FY | - EUR | 313.73% |
| 2022 Q1 | 0.84 EUR | -28.81% |
| 2022 Q2 | -0.07 EUR | -108.75% |
| 2022 Q3 | 0.14 EUR | 290.48% |
| 2022 Q4 | 0.62 EUR | 342.86% |
| 2021 Q4 | 1.18 EUR | 5144.44% |
| 2021 Q1 | 0.53 EUR | 35.9% |
| 2021 Q2 | -0.59 EUR | -211.32% |
| 2021 Q3 | 0.02 EUR | 103.81% |
| 2021 FY | - EUR | 106.44% |
| 2020 Q1 | 0.38 EUR | 1481.82% |
| 2020 Q4 | 0.39 EUR | 119.9% |
| 2020 Q2 | -2.45 EUR | -744.74% |
| 2020 FY | - EUR | -738.71% |
| 2020 Q3 | -1.96 EUR | 20.0% |
| 2019 Q1 | 0.32 EUR | 107.96% |
| 2019 Q3 | 0.26 EUR | 160.0% |
| 2019 FY | - EUR | 451.11% |
| 2019 Q4 | -0.03 EUR | -110.58% |
| 2019 Q2 | 0.10 EUR | -68.75% |
| 2018 Q1 | 0.55 EUR | 804.23% |
| 2018 Q2 | 0.22 EUR | -60.0% |
| 2018 FY | - EUR | -51.09% |
| 2018 Q3 | 0.73 EUR | 231.82% |
| 2018 Q4 | -4.02 EUR | -650.68% |
| 2017 Q2 | 0.35 EUR | -41.67% |
| 2017 FY | - EUR | -32.35% |
| 2017 Q3 | 0.22 EUR | -37.14% |
| 2017 Q1 | 0.60 EUR | -3.23% |
| 2017 Q4 | -0.08 EUR | -135.5% |
| 2016 Q1 | 0.46 EUR | -38.67% |
| 2016 FY | - EUR | 9.68% |
| 2016 Q2 | 0.42 EUR | -8.7% |
| 2016 Q3 | 0.36 EUR | -14.29% |
| 2016 Q4 | 0.62 EUR | 72.22% |
| 2015 Q2 | 0.35 EUR | -14.63% |
| 2015 Q3 | 0.30 EUR | -14.29% |
| 2015 FY | - EUR | 20.39% |
| 2015 Q1 | 0.41 EUR | 57.69% |
| 2015 Q4 | 0.75 EUR | 150.0% |
| 2014 FY | - EUR | 6.19% |
| 2014 Q2 | 0.29 EUR | -32.56% |
| 2014 Q1 | 0.43 EUR | -21.82% |
| 2014 Q4 | 0.26 EUR | 4.0% |
| 2014 Q3 | 0.25 EUR | -13.79% |
| 2013 Q1 | 0.35 EUR | 0.0% |
| 2013 Q3 | 0.22 EUR | -15.38% |
| 2013 Q4 | 0.55 EUR | 150.0% |
| 2013 Q2 | 0.26 EUR | -25.71% |
| 2013 FY | - EUR | 32.88% |
| 2012 Q3 | 0.16 EUR | 14.29% |
| 2012 Q1 | 0.32 EUR | 0.0% |
| 2012 Q4 | - EUR | -100.0% |
| 2012 FY | - EUR | -2.67% |
| 2012 Q2 | 0.14 EUR | -56.25% |
| 2011 Q3 | 0.20 EUR | -13.04% |
| 2011 FY | - EUR | 92.31% |
| 2011 Q4 | - EUR | -100.0% |
| 2011 Q1 | 0.21 EUR | 0.0% |
| 2011 Q2 | 0.23 EUR | 9.52% |
| 2010 FY | - EUR | -9.3% |
| 2010 Q3 | 0.09 EUR | -45.31% |
| 2010 Q1 | 0.19 EUR | 0.0% |
| 2010 Q2 | 0.16 EUR | -15.79% |
| 2010 Q4 | - EUR | -100.0% |
| 2009 Q1 | 0.14 EUR | 0.0% |
| 2009 FY | - EUR | -23.21% |
| 2009 Q2 | 0.17 EUR | 21.43% |
| 2009 Q4 | - EUR | -100.0% |
| 2009 Q3 | 0.08 EUR | -55.88% |
| 2008 Q1 | 0.24 EUR | 0.0% |
| 2008 Q4 | - EUR | -100.0% |
| 2008 Q3 | 0.09 EUR | -48.61% |
| 2008 Q2 | 0.18 EUR | -25.0% |
| 2008 FY | - EUR | -25.33% |
| 2007 Q4 | - EUR | -100.0% |
| 2007 Q2 | 0.14 EUR | -33.33% |
| 2007 Q1 | 0.21 EUR | 0.0% |
| 2007 FY | - EUR | 31.58% |
| 2007 Q3 | 0.37 EUR | 164.29% |
| 2006 Q4 | - EUR | -100.0% |
| 2006 FY | - EUR | 23.91% |
| 2006 Q3 | 0.10 EUR | -33.33% |
| 2006 Q1 | 0.22 EUR | 0.0% |
| 2006 Q2 | 0.15 EUR | -31.82% |
| 2005 Q2 | 0.05 EUR | -74.55% |
| 2005 Q1 | 0.20 EUR | 0.0% |
| 2005 Q3 | 0.17 EUR | 233.99% |
| 2005 FY | - EUR | -6.12% |
| 2005 Q4 | - EUR | -100.0% |
| 2004 Q1 | 0.14 EUR | 0.0% |
| 2004 Q2 | 0.04 EUR | -67.93% |
| 2004 Q3 | 0.01 EUR | -83.52% |
| 2004 FY | - EUR | -49.48% |
| 2004 Q4 | - EUR | -100.0% |
| 2003 Q3 | -0.04 EUR | -193.54% |
| 2003 FY | - EUR | 169.44% |
| 2003 Q1 | 0.20 EUR | 0.0% |
| 2003 Q2 | 0.04 EUR | -77.55% |
| 2003 Q4 | - EUR | 100.0% |
| 2002 FY | - EUR | 12.5% |
| 2002 Q4 | - EUR | -100.0% |
| 2002 Q3 | 0.22 EUR | 220.7% |
| 2002 Q1 | 0.18 EUR | 0.0% |
| 2002 Q2 | 0.07 EUR | -61.89% |
| 2001 Q2 | 0.19 EUR | 26.67% |
| 2001 FY | - EUR | -48.39% |
| 2001 Q4 | - EUR | 100.0% |
| 2001 Q3 | -0.07 EUR | -135.79% |
| 2001 Q1 | 0.15 EUR | 0.0% |
| 2000 FY | - EUR | -10.14% |
| 1999 FY | - EUR | 25.45% |
| 1998 FY | - EUR | 0.0% |
| Name | Eps | Eps Difference |
|---|---|---|
| AstraZeneca PLC | 3.84 USD | 177.865% |
| Bristol-Myers Squibb Company PFD CONV 2 | 3.88 USD | 177.062% |
| CSPC Pharmaceutical Group Limited | 0.07 USD | 4371.429% |
| Clarus Therapeutics Holdings, Inc. | -8.04 USD | 62.811% |
| Novartis AG | 7.63 USD | 139.187% |
| PT Kalbe Farma Tbk. | 0.00 USD | 76766.667% |